We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

94 hedge funds and large institutions have $639M invested in Epizyme, Inc in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,498% more call options, than puts

Call options by funds: $783K | Put options by funds: $49K

110% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 10

13% more funds holding

Funds holding: 83 → 94 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

9% less capital invested

Capital invested by funds: $699M → $639M (-$60.1M)

Holders
94
Holders Change
+11
Holders Change %
+13.25%
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
29
Reduced
29
Closed
10
Calls
$783K
Puts
$49K
Net Calls
+$734K
Net Calls Change
+$311K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$16.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.3M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$12.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.56M
5
PA
Perceptive Advisors
New York
+$7.5M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$40.3M
2
BA
BlackRock Advisors
Delaware
-$12.7M
3
DCM
Driehaus Capital Management
Illinois
-$2.58M
4
Axa
Axa
France
-$2.27M
5
SFM
Sphera Funds Management
Israel
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
HLA
51
Hamilton Lane Advisors
Pennsylvania
$460K +$528K +16,982 New
AllianceBernstein
52
AllianceBernstein
Tennessee
$453K +$137K +4,400 +36%
JRP
53
Jasper Ridge Partners
California
$437K +$501K +16,108 New
JMPWA
54
JP Morgan Private Wealth Advisors
California
$430K – – –
ARTA
55
A.R.T. Advisors
New York
$429K +$493K +15,849 New
TC
56
TFS Capital
Pennsylvania
$423K +$485K +15,605 New
TD Asset Management
57
TD Asset Management
Ontario, Canada
$417K -$165K -5,300 -26%
SO
58
STRS Ohio
Ohio
$352K +$404K +12,991 New
Swiss National Bank
59
Swiss National Bank
Switzerland
$342K +$155K +5,000 +66%
DCM
60
Dupont Capital Management
Delaware
$332K – – –
Goldman Sachs
61
Goldman Sachs
New York
$332K +$158K +5,094 +71%
Jane Street
62
Jane Street
New York
$309K -$180K -5,779 -34%
Royal London Asset Management
63
Royal London Asset Management
United Kingdom
$303K – – –
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$296K +$12.4K +400 +4%
B
65
BP
United Kingdom
$282K +$323K +10,393 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$280K – – –
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$279K – – –
NFA
68
Nationwide Fund Advisors
Ohio
$268K +$3.42K +110 +1%
AIG
69
American International Group
New York
$227K -$186 -6 -0.1%
Invesco
70
Invesco
Georgia
$223K +$256K +8,230 New
VOYA Investment Management
71
VOYA Investment Management
Georgia
$211K – – –
BA
72
BlackRock Advisors
Delaware
$177K -$12.7M -409,104 -98%
PCM
73
Prelude Capital Management
New York
$149K +$131K +4,200 +323%
Citigroup
74
Citigroup
New York
$135K -$1.92M -61,841 -93%
U
75
UBS
Switzerland
$118K +$35.1K +1,130 +35%
1 2
3
4 5

EPZM Hedge Fund Activity: Q3 2014 in Review

94 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2014, worth a combined $639M — down 8.6% from $699M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new EPZM positions and 10 closed out — a net gain of 11 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was State Street, adding an estimated $16.8M. The largest seller was NEA Management Company, cutting an estimated $40.3M.

  • 94 institutional investors held Epizyme, Inc (EPZM) as of Q3 2014, up from 83 in Q2 2014.
  • Funds reported $639M of Epizyme, Inc stock for Q3 2014, down 8.6% quarter-over-quarter.
  • 21 funds opened new Epizyme, Inc positions in Q3 2014 and 10 closed out, a net change of +11 holders.
  • The largest Epizyme, Inc buyer in Q3 2014 was State Street, an estimated $16.8M added.
  • The largest Epizyme, Inc seller in Q3 2014 was NEA Management Company, an estimated $40.3M sold.

Based on aggregated 13F filings for Q3 2014.